FP
Frederico Perego Costa
Founder & Chief Scientific Officer at Autem Therapeutics
View Frederico's Contact Info for Free. Sign Up and Get 50 Free Contacts Per Month.Get Started for Free
Work Experience
Founder & Chief Scientific Officer
2021 - Present · 3 years and 11 months
Medical Oncologist
1998 - Present · 26 years and 11 months
Telemedicine Program, Hospital Sírio Libanês
Director
1998 - 2005 · 7 years
Company Details
11-50 Employees
Autem Therapeutics is a privately held oncology therapeutic and bioelectric company headquartered in Hanover NH, USA that is developing a novel, non-invasive and non-toxic oncology treatment platform targeting HCC (liver cancer) and other solid tumor cancers. The company has received FDA breakthrough designation for its AutEMsys™ therapy for the treatment of advanced HCC patients. The AutEMsys™ therapy delivers personalized, amplitude-modulated electromagnetic (EM) frequencies (and based on initial clinical feasibility studies shows promise in shrinking cancerous tumors, enhancing quality of life and extending survival in early and advanced stage cancer patient populations. Autem Therapeutics anticipates submitting an FDA Investigational Device Exemption (IDE) to initiate FDA pivotal clinical trials in late 2022 or early 2023.
Year Founded
2017
Social Media
Linkedin
Industry
Biotechnology Research
HQ Location
35 S Main St Hanover, New Hampshire 03755, US
Keywords
bioelectricHCCsolid tumoursquality of lifesurvivalmedical deviceelectromagnetic frequencies (EM)
Discover More About Cleveland Clinic

Find verified contacts of Frederico Perego Costa in seconds from 700M people profiles. Start now!

No Credit Card Needed. By signing up, you understand and agree to Futern's Terms and Policy.